InsidersTradesSigma
Track the アステラス製薬株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €4,001.3bn. The latest transaction was disclosed on 20 January 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. Every trade is free.
Analysts rate アステラス製薬株式会社 Buy (bullish), based on 13 analysts. Average price target: JP¥2,388.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
Astellas Pharma Inc. es una compañía farmacéutica japonesa centrada en la investigación y el desarrollo de medicamentos innovadores. Se concentra principalmente en oncología, urología y enfermedades infecciosas.